ArticleCancers2023

Renal Safety Profile of BCR-ABL Tyrosine Kinase Inhibitors in a Real-Life Setting: A Study Based on Vigibase

Morgane Cellier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.